99
Views
4
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Acute lymphoblastic leukaemia cells express CCR7 but not higher amounts of IL‐10 after CD40 ligation

, , , , , , , , , , , , , & show all
Pages 695-704 | Received 18 Mar 2006, Accepted 13 Jul 2006, Published online: 08 Jul 2009
 

Abstract

Objective. Production of cytokines that support T‐cell activation and proliferation and migration to lymph nodes is one of the most important terms of cancer vaccine development. In previous studies we and others used CD40 ligation to obtain higher expression of co‐stimulatory and adhesion molecules on leukaemic cells from children with acute lymphoblastic leukaemia (ALL). This time we assess the cytokine and chemokine gene expression profile in CD40‐stimulated ALL cells. Material and methods. Malignant cells from 25 children with BCP‐ALL were stimulated (or not) with huCD40LT and rIL‐4 for 96 h. Eleven different molecule, cytokine and chemokine mRNAs levels (CCR7, IL‐23, TGF‐β‐IP, IFN‐γ, IL‐10, CD1a, CD40, CD54, CD80, CD83, CD86) were determined using the real‐time PCR technique with TaqMan chemistry using ready‐to‐use low‐density arrays for gene expression by Applied Biosystems. Results. 1) Increases in mRNA levels for CD40, CD54 and CD80 after CD40L and IL‐4 stimulation were observed, 2) CCR7 mRNA expression was higher after CD40 ligation than before the culture (p = 0.002), 3) IL‐10 mRNA expression was higher after the culture with medium than before the culture (p = 0.01). Conclusions. The results show that leukaemia‐derived dendritic cells obtained with CD40 ligation express CCR7 – chemokine is involved in migration to lymph nodes and does not produce higher amounts of IL‐10, a potent immunosuppressive cytokine. Our preclinical findings could be used in the design of immunotherapy trials for the treatment of children with ALL.

Acknowledgements

This study was supported by the Polish State Committee for Scientific Research (grant number 2P05A 166 29). We thank Marek Kubin and Kristi Phalmer from Amgen for CD40L.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.